Type VII Collagen Deficiency in the Oncogenesis of Cutaneous Squamous Cell Carcinoma in Dystrophic Epidermolysis Bullosa

被引：6

作者：

South, Andrew P. ^{[1
,11
]}

Laimer, Martin ^{[2
,3
]}

Gueye, Mouhamed ^{[4
]}

Sui, Jennifer Y. ^{[5
,6
]}

Eichenfield, Lawrence F. ^{[5
,6
]}

Mellerio, Jemima E. ^{[7
]}

Nystrom, Alexander ^{[8
,9
,10
]}

机构：

[1] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA

[2] Paracelsus Med Univ, Univ Hosp, Dept Dermatol & Allergol, Salzburg, Austria

[3] Univ Hosp, Paracelsus Med Univ, EB House Austria, Salzburg, Austria

[4] Krystal Biotech, Pittsburgh, PA USA

[5] Univ Calif San Diego, Dept Dermatol, Sch Med, San Diego, CA USA

[6] Univ Calif San Diego Sch Med, Dept Pediat, San Diego, CA USA

[7] Rady Childrens Hosp San Diego, Div Pediat Dermatol, San Diego, CA USA

[8] Guys & St Thomas NHS Fdn trust, St Johns Inst Dermatol, London, England

[9] Univ Freiburg, Med Fac, Med Ctr, Dept Dermatol, Freiburg, Germany

[10] Freiburg Inst Adv Studies, Freiburg, Germany

[11] Thomas Jefferson Univ, Dermatol & Cutaneous Biol, Sidney Kimmel Med Coll, 233 S 10th St 406 BLSB, Philadelphia, PA 19107 USA

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 11期

关键词：

FIBROBLAST-GROWTH-FACTOR; NATIONAL-EB-REGISTRY; TGF-BETA; SKIN-CANCER; T-CELLS; PROGRESSION; PREVALENCE; MECHANISMS; EXPERIENCE; MUTATIONS;

D O I：

10.1016/j.jid.2023.05.024

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Dystrophic epidermolysis bullosa is a rare genetic skin disorder caused by COL7A1 sequence variations that result in type VII collagen deficits and cutaneous and extracutaneous manifestations. One serious complication of dystrophic epidermolysis bullosa is cutaneous squamous cell carcinoma, a leading driver of morbidity and mortality, especially among patients with recessive dystrophic epidermolysis bullosa. Type VII collagen deficits alter TGFb signaling and evoke multiple other cutaneous squamous cell carcinoma progression-promoting activities within epidermal microenvironments. This review examines cutaneous squamous cell carcinoma pathophysiology in dystrophic epidermolysis bullosa with a focus on known oncogenesis pathways at play and explores the idea reduce cutaneous squamous cell carcinoma risk.

引用

页码：2108 / 2119

页数：12

共 50 条

[41] miR-29 Regulates Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa
Oever, Michael Vanden
Muldoon, Daniel
Mathews, Wendy
McElmurry, Ron
Tolar, Jakub
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (10) : 2013 - 2021
[42] INTRAEPIDERMAL RETENTION OF TYPE-VII COLLAGEN IN A PATIENT WITH RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
SMITH, LT
SYBERT, VP
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 94 (02) : 261 - 264
[43] SQUAMOUS-CELL CARCINOMA AND RECESSIVE DYSTROPHIC EPIDERMOLYSIS-BULLOSA
FOUREL, E
CLAUDY, AL
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1992, 119 (08): : 563 - 565
[44] Understanding the Pathogenesis of Recessive Dystrophic Epidermolysis Bullosa Squamous Cell Carcinoma
South, Andrew P.
O'Toole, Edel A.
DERMATOLOGIC CLINICS, 2010, 28 (01) : 171 - +
[45] RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA COMPLICATED BY SQUAMOUS-CELL CARCINOMA
TIDMAN, MJ
MACDONALD, DM
WELLS, RS
BRITISH JOURNAL OF DERMATOLOGY, 1985, 113 : 82 - 82
[46] Squamous cell carcinoma in a pregnant woman with recessive dystrophic epidermolysis bullosa
Lopes, Jorge
Baptista, Armando
Moreira, Ana
OXFORD MEDICAL CASE REPORTS, 2020, (08): : 264 - 266
[47] Rigosertib for the treatment of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa
Pourreyron, C.
Watt, S. A.
Wright, S.
Gruber, C.
Prisco, M.
McGrath, J. A.
Mellerio, J. E.
Bauer, J.
South, A.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S17 - S17
[48] Cetuximab Therapy of Metastasizing Cutaneous Squamous Cell Carcinoma in a Patient with Severe Recessive Dystrophic Epidermolysis Bullosa
Arnold, Andreas W.
Bruckner-Tuderman, Leena
Zueger, Christina
Itin, Peter H.
DERMATOLOGY, 2009, 219 (01) : 80 - 83
[49] Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases
Hwang, Austin
Kwon, Andie
Miller, Corinne H.
Reimer-Taschenbrecker, Antonia
Paller, Amy S.
ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
[50] Successful use of immunotherapy to treat advanced cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa
Duong, Tony
Wong, Debra
Barrett, Alexander
Price, Harper
BMJ CASE REPORTS, 2021, 14 (02)

← 1 2 3 4 5 →